SG11202001885WA - Topical compositions and methods for treatment - Google Patents

Topical compositions and methods for treatment

Info

Publication number
SG11202001885WA
SG11202001885WA SG11202001885WA SG11202001885WA SG11202001885WA SG 11202001885W A SG11202001885W A SG 11202001885WA SG 11202001885W A SG11202001885W A SG 11202001885WA SG 11202001885W A SG11202001885W A SG 11202001885WA SG 11202001885W A SG11202001885W A SG 11202001885WA
Authority
SG
Singapore
Prior art keywords
treatment
methods
topical compositions
topical
compositions
Prior art date
Application number
SG11202001885WA
Inventor
Steven Quay
Avadhesh Kushwaha
Edward Kisak
John Newsam
Original Assignee
Atossa Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atossa Therapeutics Inc filed Critical Atossa Therapeutics Inc
Publication of SG11202001885WA publication Critical patent/SG11202001885WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11202001885WA 2017-09-11 2018-09-10 Topical compositions and methods for treatment SG11202001885WA (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762556799P 2017-09-11 2017-09-11
US201762556920P 2017-09-11 2017-09-11
US201762556884P 2017-09-11 2017-09-11
US201862624787P 2018-01-31 2018-01-31
US201862693885P 2018-07-03 2018-07-03
PCT/US2018/050197 WO2019051370A1 (en) 2017-09-11 2018-09-10 Topical compositions and methods for treatment

Publications (1)

Publication Number Publication Date
SG11202001885WA true SG11202001885WA (en) 2020-03-30

Family

ID=65634433

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001885WA SG11202001885WA (en) 2017-09-11 2018-09-10 Topical compositions and methods for treatment

Country Status (12)

Country Link
US (2) US20200215006A1 (en)
EP (1) EP3681478A4 (en)
JP (1) JP7376105B2 (en)
KR (1) KR20200051689A (en)
CN (1) CN111212631A (en)
AU (1) AU2018329182A1 (en)
CA (1) CA3074302A1 (en)
IL (1) IL272945A (en)
MX (1) MX2020002683A (en)
SG (1) SG11202001885WA (en)
TW (1) TW201919594A (en)
WO (1) WO2019051370A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111328280A (en) 2017-09-11 2020-06-23 阿托萨治疗学公司 Methods of making and using endoxifen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004251731A1 (en) * 2003-06-23 2005-01-06 Macrochem Corporation Compositons and methods for topical administration
US20070269379A1 (en) * 2003-07-23 2007-11-22 Samir Mitragotri Penetration Enhancer Combinations for Transdermal Delivery
EP1909772A4 (en) * 2005-08-05 2011-07-13 Nuvo Res Inc Transdermal drug delivery formulation
US20120164075A1 (en) * 2006-11-21 2012-06-28 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of mammalian diseases
CA2669913C (en) * 2006-11-21 2012-09-18 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions
CA2823407C (en) * 2007-03-22 2016-10-18 Berg Pharma Llc Topical formulations having enhanced bioavailability
PT2373305T (en) * 2008-12-11 2017-06-14 Besins Healthcare Lu Sarl Transdermal pharmaceutical compositions comprising a serm
US20100317635A1 (en) * 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
WO2014012117A1 (en) * 2012-07-13 2014-01-16 South Dakota State University Compositions and methods for localized drug delivery through mammary papillae
EP3283061A4 (en) * 2015-04-14 2019-04-17 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders

Also Published As

Publication number Publication date
CA3074302A1 (en) 2019-03-14
EP3681478A1 (en) 2020-07-22
KR20200051689A (en) 2020-05-13
TW201919594A (en) 2019-06-01
JP2020533342A (en) 2020-11-19
JP7376105B2 (en) 2023-11-08
US20200215006A1 (en) 2020-07-09
WO2019051370A1 (en) 2019-03-14
AU2018329182A1 (en) 2020-03-19
US20240148675A1 (en) 2024-05-09
CN111212631A (en) 2020-05-29
IL272945A (en) 2020-04-30
MX2020002683A (en) 2020-09-25
EP3681478A4 (en) 2021-07-14

Similar Documents

Publication Publication Date Title
IL273823A (en) Methods and compositions for topical delivery
EP4139348A4 (en) Methods and compositions for treating virus-associated inflammation
IL269150A (en) Compositions and methods for treating cancer
IL304820A (en) Compositions and methods for treating cancer
EP3490622C0 (en) Methods and compositions for wound healing
PT3377516T (en) Methods and compositions for treating cancer
EP3408344A4 (en) Well treatment methods and compositions
IL269157A (en) Compositions and methods for treating cancer
SI3189074T1 (en) Compositions and methods for treating and preventing inflammation
IL256523A (en) Compositions and methods for treating cancer
IL271256A (en) Compositions and methods for treating tauopathies
HK1258696A1 (en) Novel compositions and methods for treating or preventing dermal disorders
EP3347025A4 (en) Methods and compositions for cancer treatment
EP3164139A4 (en) Topical compositions and methods for treating wounds
IL291266A (en) Compositions and methods for treating infections
RS63754B1 (en) Compositions and methods for wound treatment
EP3262065C0 (en) Methods and compositions for treating dystroglycanopathy disorders
IL255638A (en) Compositions and methods for treating cancer
IL272782A (en) Compositions and methods for treating cancer
IL272945A (en) Topical compositions and methods for treatment
HK1250958A1 (en) Compositions and methods for treating cancer
IL257407A (en) Compositions and methods for treating wounds
EP3334424A4 (en) Compositions and methods for treating alopecia
IL280569A (en) Uvb-induced photodamages: compositions and methods for topical treatment
AU2017904364A0 (en) Methods and compositions for treating skin